One hundred and twenty-six epidemiologically sequential, unrelated, carbapenem-resistant Acinetobacter baumannii isolates from nine hospitals in six countries of South America were collected between July 2013 and June 2014. Genes coding for Ambler class D and B carbapenemases were sought by PCR. All isolates were typed using the 3-locus sequence typing and bla OXA-51-like sequence-based typing techniques. The bla OXA-23 gene was recovered in all the participating hospitals and in all the isolates of seven of nine medical centres. The bla OXA-72 gene was only recovered in the two medical centres from Guayaquil city, Ecuador. Trilocus sequence typing revealed the presence of sequence groups SG2, SG4 and SG5. bla OXA-51-like sequence-based typing revealed the presence of bla OXA-132 , bla OXA-65 , bla OXA-69 and bla OXA-64 . Our results showed that the population of carbapenem-resistant A. baumannii in South America was principally associated with ST79, ST25 and ST15 (92 %) and harboured the bla OXA-23 gene mainly. CC2 was not detected.
INTRODUCTION
Healthcare-associated infections due to Acinetobacter baumannii are an increasing problem globally. Outbreaks have been intensively documented worldwide and are usually caused by carbapenem-resistant strains (Peleg et al., 2008) . The clonal study of hospital strains is very important in terms of understanding the epidemiology of these outbreaks. Different tools have been proposed to investigate the epidemiology of A. baumannii outbreaks. bla OXA-51-like sequence-based typing (SBT) (Pournaras et al., 2014 ) and 3-locus sequence typing (3-LST) (Turton et al., 2007) represent economic and rapid methodologies, which showed a discriminatory power similar to multilocus sequence typing (MLST).
In Europe and various other regions it was reported that these outbreak strains belonged mainly to three international clones, I, II and III, and that the production of OXA-23 represented the main mechanism of carbapenem resistance (Karah et al., 2012) . In South America (SA), most of the studies were performed in Brazil, Colombia and Argentina and showed epidemiological features different from those in Europe because clones I and II are absent or sporadic (Clímaco et al., 2013; Martins et al., 2013; Stietz et al., 2013; Vasconcelos et al., 2015) . However, to our knowledge, no international studies have been performed in other countries of SA to evaluate the epidemiology of carbapenem-resistant A. baumannii (CR-Ab) strains. Recently, Labarca et al. (2016) revised the carbapenemresistant rates in A. baumannii in Latin America. These authors found that the incidence of CR-Ab varied widely across SA countries, from 19 % in Bolivia to 81 % in Argentina.
The aim of this study was to determine the molecular epidemiology and the molecular mechanisms of carbapenem resistance in isolates of CR-Ab recovered in nine unrelated hospitals from six countries in SA during the years 2013 and 2014. The average distance between the different cities is more than 1000 km, and only Buenos Aires city and Asunción are capital cities.
These isolates were identified at the Hospital de Clínicas Jos e de San Martín using standard biochemical tests, and genospecies was confirmed using matrix-assisted laser desorption and the ionization time-of-flight MS method and detection of bla OXA-51 as previously described by Alvarez-Buylla et al. (2012) . The MICs to imipenem and meropenem were determined using the agar dilution method. Interpretations were made according to the Clinical and Laboratory Standards Institute breakpoints (CLSI, 2013) . Genes coding for Ambler class B and D (carbapenem-hydrolyzing class D b-lactamase) carbapenemases were sought by PCR using specific primers followed by sequencing (Poirel et al., 2011; Woodford et al., 2006) . Repetitive extragenic palindromic DNA sequence-based PCR (rep-PCR) was used for epidemiological analysis (Quelle et al., 2001) . Strain delineation was inferred in terms of percentage of banding patterns using the Dice coefficient. Clustering was performed by the unweighted pair-group method using arithmetic average. The cut-off level for PCR-pattern delineation was 80 % of similarity. All isolates were typed using the 3-LST protocol developed by the United Kingdom health protection agency, involving two multiplex PCRs and bla OXA-51-like sequence-based typing (Pournaras et al., 2014; Turton et al., 2007) . The results from SBT or 3-LST were considered valid if the obtained profiles had been previously assigned to a clone or sequence type (ST) by the MLST technique; otherwise, they were considered as indeterminate (Karah et al., 2012; Pournaras et al., 2014; Turton et al., 2007) .
RESULTS AND DISCUSSION
The carbapenem MIC in all isolates was >4 µg ml À1 . The presence of the bla OXA-51 gene was detected in all isolates, whereas none harboured metallo-b-lactamase genes. IMPtype enzymes have previously been detected in Brazil, and more recently NDM-1 has emerged in SA in different Acinetobacter species (Pillonetto et al., 2014; Togmin et al., 2006) . Eighteen rep-PCR patterns were identified. Among these, 10 patterns (covering 15 A. baumannii isolates) were considered sporadic. However, 8 rep-PCR patterns, covering 111 isolates, were considered endemic or epidemic strains.
The bla OXA-23 gene was recovered in all participating medical centres and in all isolates from seven of nine centres. The worldwide dissemination of bla OXA-23 is related to the international clone I or II (Mugnier et al., 2010) . In SA, this carbapenemase has been commonly associated with ST79 (Grosso et al., 2011) . In agreement with previous reports, ST79 bla OXA-23 -producing isolates were reported in half of the participating countries, but this carbapenemase was also detected in all STs recovered in this study (ST15, ST25, ST1 and ST79) ( Table 1 ).
The bla OXA-58 gene was been detected in this study as expected, since bla OXA-58 has been progressively replaced by bla OXA-23 in recent years worldwide. In Bolivia and Chile, previous studies of outbreaks by CR-Ab showed the presence of OXA-58 as the main carbapenem-resistant mechanism (Bruno et al., 2013; Opazo et al., 2012; Sevillano et al., Carbapenem-resistant A. baumannii in South America 2012). The bla OXA-72 gene was recovered only in the two participating hospitals from Guayaquil city, Ecuador. This carbapenemase often plasmid mediated, has been reported to cause hospital outbreaks in many intensive care units worldwide and recently in North America (Alcantar Curiel et al., 2014; Poirel et al., 2010) . In SA, isolates carrying bla OXA-72 have been reported in Ecuador, and a national surveillance study carried out in Brazil showed that the strains belonged to ST79 (Nuñez-Quezada et al., 2016; Vasconcelos et al., 2015) . In our study, the presence of bla OXA-72 in different STs (ST15 and ST79) and in isolates belonging to ST15 in different rep-PCR patterns may indicate not only clonal dissemination but also plasmid dispersion of the enzyme (Table 1) .
MLST is the gold standard technique for epidemiological study. However, SBT and 3-LST data correlated well with MLST with respect to the identification of the major international lineages. In this work, we identified only four previously characterized STs and they are as follows: ST15 (39.7 % of isolates) assigned to SG5 and harbouring bla OXA-132 ; ST25 (37.3 % of isolates) assigned to SG4 and harbouring bla OXA-64 ; ST1 (7.9 % of isolates) assigned to SG2 and harbouring bla OXA-69; and ST79 (15.1 % of isolates) harbouring bla OXA-65 . ST79 has not been assigned to any SG to date. The weak performance of 3-LST in isolates from SA has already been communicated (Martins et al., 2013) .
Although only limited information is available concerning CR-Ab strains in SA, the predominant circulation of ST79 has been reported in previous studies from Brazil and Argentina (Stietz et al., 2013; Vasconcelos et al., 2015) . This clone has also been called WWW5 or Pan-American clone because it was found in North, Central and South America (Higgins et al., 2010) . However, in this study ST79 was not the most frequently isolated ST; this ST was only predominant in Paraguay and in Mendoza, Argentina, and it was also detected in sporadic isolates in Ecuador (Table 1) . ST25, also called WWW7, was responsible for epidemics in different European and Asian countries (Karah et al., 2012) . In SA, it has previously been detected but only sporadically or in low percentages. ST25 was the ST recovered in most of the countries included in this study (four out of six) and it was the majority ST in three countries (Argentina, Bolivia and Uruguay), which shows a change compared to previous reports (Merkier et al., 2008; Paciel et al., 2011; Rodriguez et al., 2010) (Table 1) .
ST15 was predominant in isolates from Ecuador and Chile, but it was not detected in other countries. Isolates belonging to ST15 had previously been reported in Chile (Higgins et al., 2010) (Table 1) .
It is known that the international clones I, II and III have low prevalence in the A. baumannii population in SA. In this work, clone II was not detected and isolates belonging to clone I were only recovered in Buenos Aires, Argentina. This clone had previously been detected in Argentina and Brazil but in percentages lower than 20 % (Merkier et al., 2008) .
In the present study carried out in SA, we could identify similar features compared to other regions regarding CR-Ab epidemiology: (i) a clear predominance of the bla oxa-23 gene in CR-Ab, (ii) the emergence of the bla OXA-72 gene in Ecuador, (iii) the spread of isolates belonging to ST25 and finally, and contrary to what was observed worldwide, (iv) the low prevalence of the international clones I, II and III in SA.
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